Proffitt & Goodson’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Proffitt & Goodson’s Portfolio MKUL Stock Details MKUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25	Closed	-$4	–	238
2023 Q3	$4	Hold	25	–	–	﹤0.01%	230
2023 Q2	$59	Hold	25	–	–	﹤0.01%	223
2023 Q1	$43	Hold	25	–	–	﹤0.01%	230
2022 Q4	$78	Hold	25	–	–	﹤0.01%	235
2022 Q3	$0	Hold	25	–	–	﹤0.01%	269
2022 Q2	$0	Hold	25	–	–	﹤0.01%	281
2022 Q1	$0	Hold	25	–	–	﹤0.01%	288
2021 Q4	$0	Buy	+25	New	+$549	﹤0.01%	264

Other funds holding MKUL

FGN

Foundry Group Next Boulder, Colorado $21.1M AUM 35.51% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SFG

SVB Financial Group Dallas, Texas $434K AUM 277.67% 1-Year Est. Return

Proffitt & Goodson's MKUL Position: Q4 2023 in Review

Proffitt & Goodson sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 25 shares — an estimated $4 sold.

Proffitt & Goodson first reported a position in MKUL in Q4 2021 and held it in 8 quarters. The position peaked at $78 in Q4 2022. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

Proffitt & Goodson reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Proffitt & Goodson sold 25 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $4.
Proffitt & Goodson first reported a position in Molekule Group, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Proffitt & Goodson's Molekule Group, Inc. Common Stock position peaked at $78 in Q4 2022.
3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on Proffitt & Goodson's 13F filing for Q4 2023, filed 24 Jan 2024.